Basal-Like Breast Carcinoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Basal-Like Breast Carcinoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT05909332

Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (…

This is a randomized, open-label phase III clinical trial comparing antivascular therapy combined with standard chemotherapy and standard chemotherapy in adjuva…

China764 participantsStarted 2023-06-20

Treatment: Antivascular therapy, Chemotherapy

All recent trials (12 shown)

Active — Not RecruitingPhase 3

NCT02445391

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

This randomized phase III trial studies how well cisplatin or carboplatin (platinum based chemotherapy) works compared to capecitabine in treating patients with…

United States415 participantsStarted 2015-10-20

Treatment: Capecitabine, Carboplatin

WithdrawnPhase 3

NCT06585969

A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastat…

The objective of this trial, DBCG R25, will be to evaluate the effect of trastuzumab-deruxtecan versus standard of care on progression-free survival (PFS) in fi…

Location not specified0Started 2026-01-01

Treatment: Trastuzumab deruxtecan (T-DXd), Ribociclib with ET

Basal-Like Breast Carcinoma

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (…

All recent trials (12 shown)

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastat…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (…

All recent trials (12 shown)

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastat…

Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer Patients

Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carb…

Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy

Study of Erlotinib and Metformin in Triple Negative Breast Cancer

Debio 1143 in Combination With Carboplatin and Paclitaxel in Patient With Advanced Solid Malignancies

Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [P…

Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast…

Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma